These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 9233628)
21. Analysis of the AP-1 sites in the IL-2 promoter. Jain J; Valge-Archer VE; Rao A J Immunol; 1992 Feb; 148(4):1240-50. PubMed ID: 1737937 [TBL] [Abstract][Full Text] [Related]
22. Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-kappaB/Rel transcription factors. Maggirwar SB; Harhaj EW; Sun SC Mol Cell Biol; 1997 May; 17(5):2605-14. PubMed ID: 9111330 [TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor-I augments interleukin-8 promoter activity through induction of activator protein-1 complex formation. Kooijman R; Coppens A; Van den Keybus C Int J Biochem Cell Biol; 2006; 38(11):1957-64. PubMed ID: 16846747 [TBL] [Abstract][Full Text] [Related]
24. Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells. Iwai K; Mori N; Oie M; Yamamoto N; Fujii M Virology; 2001 Jan; 279(1):38-46. PubMed ID: 11145887 [TBL] [Abstract][Full Text] [Related]
25. Cooperative binding and synergistic activation by RelA and C/EBPbeta on the intercellular adhesion molecule-1 promoter. Catron KM; Brickwood JR; Shang C; Li Y; Shannon MF; Parks TP Cell Growth Differ; 1998 Nov; 9(11):949-59. PubMed ID: 9831247 [TBL] [Abstract][Full Text] [Related]
26. Nuclear transcription factors that bind to elements of the IL-2 promoter. Induction requirements in primary human T cells. Granelli-Piperno A; Nolan P J Immunol; 1991 Oct; 147(8):2734-9. PubMed ID: 1655897 [TBL] [Abstract][Full Text] [Related]
27. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter. Thomas RS; Tymms MJ; McKinlay LH; Shannon MF; Seth A; Kola I Oncogene; 1997 Jun; 14(23):2845-55. PubMed ID: 9190901 [TBL] [Abstract][Full Text] [Related]
28. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT. Whisler RL; Beiqing L; Chen M Cell Immunol; 1996 May; 169(2):185-95. PubMed ID: 8620546 [TBL] [Abstract][Full Text] [Related]
29. Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element. Good L; Maggirwar SB; Sun SC EMBO J; 1996 Jul; 15(14):3744-50. PubMed ID: 8670878 [TBL] [Abstract][Full Text] [Related]
30. Delta-opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT/AP-1-binding promoter element. Hedin KE; Bell MP; Kalli KR; Huntoon CJ; Sharp BM; McKean DJ J Immunol; 1997 Dec; 159(11):5431-40. PubMed ID: 9548483 [TBL] [Abstract][Full Text] [Related]
31. Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells. Nishiyama S; Manabe N; Kubota Y; Ohnishi H; Kitanaka A; Tokuda M; Taminato T; Ishida T; Takahara J; Tanaka T Int Immunopharmacol; 2005 Apr; 5(4):699-710. PubMed ID: 15710339 [TBL] [Abstract][Full Text] [Related]
32. The -180 site of the IL-2 promoter is the target of CREB/CREM binding in T cell anergy. Powell JD; Lerner CG; Ewoldt GR; Schwartz RH J Immunol; 1999 Dec; 163(12):6631-9. PubMed ID: 10586058 [TBL] [Abstract][Full Text] [Related]
33. CD28 costimulation augments IL-2 secretion of activated lamina propria T cells by increasing mRNA stability without enhancing IL-2 gene transactivation. Gonsky R; Deem RL; Lee DH; Chen A; Targan SR J Immunol; 1999 Jun; 162(11):6621-9. PubMed ID: 10352279 [TBL] [Abstract][Full Text] [Related]
35. Negative cross-talk between the human orphan nuclear receptor Nur77/NAK-1/TR3 and nuclear factor-kappaB. Harant H; Lindley IJ Nucleic Acids Res; 2004; 32(17):5280-90. PubMed ID: 15466594 [TBL] [Abstract][Full Text] [Related]
36. Prostaglandin E2 inhibits the nuclear transcription of the human interleukin 2, but not the Il-4, gene in human T cells by targeting transcription factors AP-1 and NF-AT. Paliogianni F; Boumpas DT Cell Immunol; 1996 Jul; 171(1):95-101. PubMed ID: 8660843 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of CD28/CD3-mediated costimulation of naive and memory human T lymphocytes by intracellular incorporation of polyclonal antibodies specific for the activator protein-1 transcriptional complex. Woodside DG; McIntyre BW J Immunol; 1998 Jul; 161(2):649-58. PubMed ID: 9670939 [TBL] [Abstract][Full Text] [Related]
38. Expression of the leukocyte early activation antigen CD69 is regulated by the transcription factor AP-1. Castellanos MC; Muñoz C; Montoya MC; Lara-Pezzi E; López-Cabrera M; de Landázuri MO J Immunol; 1997 Dec; 159(11):5463-73. PubMed ID: 9580241 [TBL] [Abstract][Full Text] [Related]
39. Cooperation of binding sites for STAT6 and NF kappa B/rel in the IL-4-induced up-regulation of the human IgE germline promoter. Messner B; Stütz AM; Albrecht B; Peiritsch S; Woisetschläger M J Immunol; 1997 Oct; 159(7):3330-7. PubMed ID: 9317131 [TBL] [Abstract][Full Text] [Related]
40. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Zerbini LF; Wang Y; Cho JY; Libermann TA Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]